Researcher , National Research and Innovation Agency of Indonesia (Badan Riset dan Inovasi Nasional, BRIN) , Indonesia.
Dr. Imam Kambali is a researcher at the National Research and Innovation Agency (BRIN) of Indonesia, specializing in nuclear physics, nuclear engineering, and accelerator applications. His work primarily focuses on the production of radioisotopes using both cyclotron and reactor-based methods. Dr. Kambali has made significant contributions to the field through his research on proton-induced nuclear reactions and secondary neutron irradiation. His career includes extensive involvement in the development of advanced technologies for nuclear medicine and diagnostics.
Profile
Scopus
Education
Dr. Kambali earned his Ph.D. in Physics from University College Dublin, National University of Ireland, where he worked under the guidance of Prof. Gerry O’Sullivan and Prof. Padraig Dunne. He obtained his Master of Philosophy in Physics from the University of Newcastle, Australia, supervised by Prof. John O’Connor and Prof. Bruce King. He holds a Bachelor’s degree in Nuclear Engineering from Gadjah Mada University, Indonesia, where he was mentored by Dr.-Ing. Kusnanto and Drs. Tjipto Sujitno.
Experience
Dr. Kambali’s professional career began at Indonesia’s National Nuclear Energy Agency (BATAN) where he worked as a researcher from 2014 to 2021. He then transitioned to the National Research and Innovation Agency (BRIN) where he continues to lead research on nuclear technologies. He is also a member of multiple prestigious organizations, including the Indonesian Researcher Union and the Physical Society of Indonesia, reflecting his dedication to advancing nuclear science.
Research Interests
Dr. Kambali’s research focuses on nuclear physics, particularly the production of radioisotopes for medical and industrial applications. He is involved in both cyclotron and reactor-based methods of radioisotope production, with special attention to proton-induced nuclear reactions. His work has contributed to advancements in positron emission tomography (PET) imaging and the development of novel diagnostic tools in nuclear medicine.
Awards
Dr. Kambali has been recognized for his contributions to nuclear science through numerous awards and accolades throughout his career. His work on the development of radioisotope production methods has been celebrated both in Indonesia and internationally, highlighting his influence on nuclear medicine and accelerator technology research.
Publications
Dr. Kambali has published extensively in high-impact journals. Some of his notable publications include:
- Development of target holder for the first experiment on an alternative route for 64Cu radioisotope production – Nuclear Science and Engineering, 2024. (Cited by)
- Preliminary Study on Tandem Electrostatic Accelerator for The Ion Accelerator Facility – AIP Conference Proceedings, 2024.
- Cerium-139 Radionuclide Production from Proton-Induced Nuclear Reaction – AIP Conference Proceedings, 2024.
- Optimum radioactivity yield of Zirconium-89 radionuclide applicable for radioimmuno-PET imaging – Journal of Physics, 2023.
- Construction and Building Materials – 2023, (Cited by).
Conclusion
Dr. Imam Kambali’s exceptional research contributions, particularly in nuclear physics and radiopharmaceuticals, make him a strong candidate for the Best Researcher Award. His work’s impact on medical diagnostics, coupled with a strong publication record and international exposure, highlights his dedication to advancing nuclear science. Further broadening his research’s interdisciplinary scope and increasing his leadership in professional organizations could amplify his already significant contributions.